Evidence map›Paper›PMID 36977817›Full record

ArticleScientific reports2023

Transcriptomics of CD29

Karen Eastlake, Joshua Luis, Weixin Wang, William Lamb, Peng T Khaw, G Astrid Limb

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Karen EastlakeNIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK. k.eastlake@ucl.ac.uk.
Joshua LuisNIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.
Weixin WangNIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.
William LambNIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.
Peng T KhawNIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.
G Astrid LimbNIHR Biomedical Research Centre at Moorfields Eye Hospital, UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK. g.limb@ucl.ac.uk.
Moorfields Eye Hospital NHS Foundation Trust · GB

Funding

Department of HealthMedical Research Council MR/K008722/1Medical Research Council MR/P01660X/1
6 · The paper itself

Abstract

Müller glia play very important and diverse roles in retinal homeostasis and disease. Although much is known of the physiological and morphological properties of mammalian Müller glia, there is still the need to further understand the profile of these cells during human retinal development. Using human embryonic stem cell-derived retinal organoids, we investigated the transcriptomic profiles of CD29

Indexed as

Stem CellsTranscriptomeAnimalsCell DifferentiationCell ProliferationEpendymoglial CellsHumansHyaluronan ReceptorsIntegrin beta1MammalsNeurogliaOrganoidsRetinaCD44 protein, humanHyaluronan ReceptorsIntegrin beta1Itgb1 protein, human

Identifiers

PMID36977817
PMCPMC10050419
OpenAlexW4361204952

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.